US equities
|
SPCX
$159.31
▲+0.00%
META
$697.52
▲+0.00%
TSLA
$386.47
▲+0.00%
MU
$913.67
▲+0.00%
NVDA
$221.97
▲+0.00%
GOOGL
$334.76
▲+0.00%
SNDK
$1,378.22
▲+0.00%
INTC
$92.96
▲+0.00%
SPCX
$159.31
▲+0.00%
META
$697.52
▲+0.00%
TSLA
$386.47
▲+0.00%
MU
$913.67
▲+0.00%
NVDA
$221.97
▲+0.00%
GOOGL
$334.76
▲+0.00%
SNDK
$1,378.22
▲+0.00%
INTC
$92.96
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by IMU Biosciences
IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease
October 19, 2026
From
IMU Biosciences
Via
Business Wire
Tickers
WAT
IMU Biosciences and Eurofins Transplant Genomics Form Strategic Partnership to Advance Transplant-Related Clinical Development Programmes
September 09, 2026
From
IMU Biosciences
Via
Business Wire
IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine
June 24, 2026
From
IMU Biosciences
Via
Business Wire
IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease
June 02, 2026
From
IMU Biosciences
Via
Business Wire